Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa Klettner

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Drug News & Perspectives|August 31, 2004
The induction of heat shock proteins as a potential strategy to treat neurodegenerative disordersAlexa Klettner
Medizinische Monatsschrift Fur Pharmazeuten|September 15, 2015
[Age-related macular degeneration - biology and treatment]Alexa Klettner
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Oxidative stress induced cellular signaling in RPE cellsAlexa Klettner
Marine Drugs|February 6, 2016
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A HypothesisAlexa Klettner
British Journal of Pharmacology|March 19, 2003
The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock responseAlexa Klettner, Thomas Herdegen
International Journal of Molecular Sciences|December 9, 2020
Fucoidans as Potential Therapeutics for Age-Related Macular Degeneration-Current Evidence from In Vitro ResearchPhilipp Dörschmann, Alexa Klettner
Investigative Ophthalmology & Visual Science|April 29, 2008
Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathwaysAlexa Klettner, Johann Roider
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 16, 2009
Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinasesAlexa Klettner, Johann Roider
International Journal of Molecular Sciences|August 27, 2021
Retinal Pigment Epithelium Expressed Toll-like Receptors and Their Potential Role in Age-Related Macular DegenerationAlexa Klettner, Johann Roider
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
FK506 and its analogs - therapeutic potential for neurological disordersAlexa Klettner, Thomas Herdegen
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Drug News & Perspectives|August 31, 2004
The induction of heat shock proteins as a potential strategy to treat neurodegenerative disordersAlexa Klettner
Medizinische Monatsschrift Fur Pharmazeuten|September 15, 2015
[Age-related macular degeneration - biology and treatment]Alexa Klettner
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Oxidative stress induced cellular signaling in RPE cellsAlexa Klettner
Marine Drugs|February 6, 2016
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A HypothesisAlexa Klettner
British Journal of Pharmacology|March 19, 2003
The immunophilin-ligands FK506 and V-10,367 mediate neuroprotection by the heat shock responseAlexa Klettner, Thomas Herdegen
International Journal of Molecular Sciences|December 9, 2020
Fucoidans as Potential Therapeutics for Age-Related Macular Degeneration-Current Evidence from In Vitro ResearchPhilipp Dörschmann, Alexa Klettner
Investigative Ophthalmology & Visual Science|April 29, 2008
Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathwaysAlexa Klettner, Johann Roider
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 16, 2009
Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinasesAlexa Klettner, Johann Roider
International Journal of Molecular Sciences|August 27, 2021
Retinal Pigment Epithelium Expressed Toll-like Receptors and Their Potential Role in Age-Related Macular DegenerationAlexa Klettner, Johann Roider
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
FK506 and its analogs - therapeutic potential for neurological disordersAlexa Klettner, Thomas Herdegen
Pageof 9